Alitretinoin
Back to searchMolecule Structure
Scientific Name
Alitretinoin
Description of the Drug
Alitretinoin is a vitamin A derivative used to treat Kaposi’s sarcoma and used off label to treat chronic hand eczema and psoriasis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00523
http://www.drugbank.ca/drugs/DB00523
Brand Name(s)
Panretin, Toctino
Company Owner(s)
Concordia Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Retinoid receptor | PROTEIN FAMILY | AGONIST | CHEMBL2363071 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL18666 | ||
| Human Metabolome Database | HMDB0002369 | ||
| DrugBank | DB00523 | ||
| PubChem: Thomson Pharma | 14898408 | ||
| PubChem | 449171 | ||
| NMRShiftDB | 60020629 | ||
| LINCS | LSM-42856 | ||
| PDBe | 9CR | ||
| BindingDB | 31892 | ||
| EPA CompTox Dashboard | DTXSID6040404 | ||
| LipidMaps | LMPR01090022 | ||
| DrugCentral | 3862 | ||
| Metabolights | MTBLC50648 | ||
| Brenda | 62226 | 9774 | 32134 |
| ChemicalBook | CB2386395 | CB3222630 | |
| Guide to Pharmacology | 2645 | 5383 | |
| rxnorm | PANRETIN | ALITRETINOIN | |
| PubChem: Drugs of the Future | 12014910 | ||
| KEGG Ligand | C15493 | ||
| ChEBI | 50648 | ||
| ZINC | ZINC000012661824 |
